About this scholarly article

C41. EMERGING PHARMACOLOGY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: MECHANISMS AND OUTCOMES - GW642444, a Novel Inhaled Long-acting Beta2 Adrenoceptor Agonist (LABA), At Single Doses Of 25, 50 And 100mcg, Is Well Tolerated And Demonstrates Prolonged Bronchodilation In COPD Patients by Kempsford, Rodger; Norris, Virginia; Siederer, Sarah is a scholarly article available to read on EtoBox.

Author

Kempsford, Rodger; Norris, Virginia; Siederer, Sarah

Publisher

American Thoracic Society

Published

2010

Language

EN